002349 精华制药
午间休市 07-01 11:30:00
资讯
新帖
简况
精华制药（002349）披露完成工商变更登记并换发营业执照公告，5月26日股价下跌0.43%
证券之星 · 05-26
精华制药（002349）披露完成工商变更登记并换发营业执照公告，5月26日股价下跌0.43%
精华制药（002349）披露2025年年度权益分派实施公告，5月21日股价下跌1.94%
证券之星 · 05-21
精华制药（002349）披露2025年年度权益分派实施公告，5月21日股价下跌1.94%
股市必读：精华制药（002349）5月15日董秘有最新回复
证券之星 · 05-18
股市必读：精华制药（002349）5月15日董秘有最新回复
精华制药：2025年度实现归母净利润2.30亿元，同比增长8.38%
证券之星 · 05-15
精华制药：2025年度实现归母净利润2.30亿元，同比增长8.38%
精华制药（002349）披露2025年年度股东会法律意见书，5月14日股价下跌1.22%
证券之星 · 05-14
精华制药（002349）披露2025年年度股东会法律意见书，5月14日股价下跌1.22%
股市必读：精华制药（002349）5月6日董秘有最新回复
证券之星 · 05-07
股市必读：精华制药（002349）5月6日董秘有最新回复
每周股票复盘：精华制药（002349）股东户数下降3.79%，一季报净利增5.87%
证券之星 · 05-03
每周股票复盘：精华制药（002349）股东户数下降3.79%，一季报净利增5.87%
图解精华制药一季报：第一季度单季净利润同比增长5.87%
证券之星 · 04-29
图解精华制药一季报：第一季度单季净利润同比增长5.87%
精华制药(002349)3月31日股东户数8.07万户，较上期减少3.79%
证券之星 · 04-29
精华制药(002349)3月31日股东户数8.07万户，较上期减少3.79%
精华制药（002349）2025年年报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 04-24
精华制药（002349）2025年年报简析：营收净利润同比双双增长，盈利能力上升
精华制药（002349）披露“质量回报双提升”行动方案，4月23日股价下跌2.04%
证券之星 · 04-23
精华制药（002349）披露“质量回报双提升”行动方案，4月23日股价下跌2.04%
精华制药(002349)3月31日股东户数8.07万户，较上期减少3.79%
证券之星 · 04-22
精华制药(002349)3月31日股东户数8.07万户，较上期减少3.79%
股市必读：精华制药（002349）3月23日收盘跌8.13%，主力净流入1461.69万元
证券之星 · 03-24
股市必读：精华制药（002349）3月23日收盘跌8.13%，主力净流入1461.69万元
精华制药：公司现金流状况良好
证券之星 · 02-05
精华制药：公司现金流状况良好
精华制药最新公告：孙公司宁夏森萱因污染环境罪被判处罚金五十万元
证券之星 · 2025-12-25
精华制药最新公告：孙公司宁夏森萱因污染环境罪被判处罚金五十万元
精华制药：玛巴洛沙韦尚未具备商业化生产销售条件
证券之星 · 2025-12-09
精华制药：玛巴洛沙韦尚未具备商业化生产销售条件
精华制药：二氧五环产销量基本保持平稳
证券之星 · 2025-12-09
精华制药：二氧五环产销量基本保持平稳
精华制药：正柴胡饮颗粒入选流感治疗指南
证券之星 · 2025-12-08
精华制药：正柴胡饮颗粒入选流感治疗指南
精华制药：为遵循信息披露公平原则,公司会在定期报告披露相对应时点股东人数
证券之星 · 2025-03-06
精华制药：为遵循信息披露公平原则,公司会在定期报告披露相对应时点股东人数
精华制药：公司尚在进行项目前期可行性方案论证等工作
证券之星 · 2025-02-18
精华制药：公司尚在进行项目前期可行性方案论证等工作
加载更多
公司概况
公司名称：
精华制药集团股份有限公司
所属行业：
医药制造业
上市日期：
2010-02-03
主营业务：
精华制药集团股份有限公司的主营业务是传统中成药制剂、化学原料药及中间体、化工医药中间体、中药材及中药饮片、大健康产品等的研发、生产和销售。公司的主要产品是王氏保赤丸、季德胜蛇药片、正柴胡饮颗粒、黄芪泡腾片、当归、白芍、苯巴比妥、氟尿嘧啶、二氧六环、甲基肼。
发行价格：
19.80
{"stockData":{"symbol":"002349","market":"SZ","secType":"STK","nameCN":"精华制药","latestPrice":6.37,"timestamp":1782880845000,"preClose":6.21,"halted":0,"volume":5941006,"delay":0,"changeRate":0.0258,"floatShares":814000000,"shares":831000000,"eps":0.2683,"marketStatus":"午间休市","change":0.16,"latestTime":"07-01 11:30:00","open":6.21,"high":6.37,"low":6.14,"amount":37246600,"amplitude":0.037,"askPrice":6.37,"askSize":434,"bidPrice":6.36,"bidSize":326,"shortable":0,"etf":0,"ttmEps":0.2683,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782882000000},"marketStatusCode":3,"adr":0,"adjPreClose":6.21,"symbolType":"stock","openAndCloseTimeList":[[1782869400000,1782876600000],[1782882000000,1782889200000]],"highLimit":6.83,"lowLimit":5.59,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":831128308,"isCdr":false,"pbRate":1.83,"roa":"--","peRate":23.74208,"roe":"2.36%","epsLYR":0.2678,"committee":-0.242144,"marketValue":5294000000,"turnoverRate":0.0073,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-07-02。","floatMarketCap":5186000000},"requestUrl":"/m/hq/s/002349","defaultTab":"news","newsList":[{"id":"2638543763","title":"精华制药（002349）披露完成工商变更登记并换发营业执照公告，5月26日股价下跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638543763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638543763?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:44","pubTimestamp":1779806662,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，精华制药报收于6.93元，较前一交易日下跌0.43%，最新总市值为57.6亿元。该股当日开盘6.95元，最高6.98元，最低6.87元，成交额达4847.5万元，换手率为0.86%。近日，精华制药集团股份有限公司发布公告称，公司已完成工商变更登记并换发营业执照。公司经营范围新增“药品互联网信息服务”，注册资本由829,674,908股变更为831,128,308股，对应注册资本为83112.8308万元。此次变更已取得南通市数据局核发的新营业执照，同时《公司章程修正案》已完成备案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637292384","title":"精华制药（002349）披露2025年年度权益分派实施公告，5月21日股价下跌1.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637292384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637292384?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:07","pubTimestamp":1779358037,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，精华制药报收于7.06元，较前一交易日下跌1.94%，最新总市值为58.68亿元。该股当日开盘7.22元，最高7.27元，最低7.03元，成交额达8048.59万元，换手率为1.38%。精华制药于2026年5月21日披露《2025年年度权益分派实施公告》。公告显示，公司2025年年度权益分派方案已获股东会审议通过，以实施权益分派股权登记日总股本831,128,308股为基数，向全体股东每10股派0.9元现金（含税）。股权登记日为2026年5月28日，除权除息日为2026年5月29日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636160530","title":"股市必读：精华制药（002349）5月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2636160530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636160530?lang=zh_cn&edition=full","pubTime":"2026-05-18 04:36","pubTimestamp":1779050173,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，精华制药报收于7.19元，下跌0.96%，换手率1.57%，成交量12.75万手，成交额9205.33万元。来自公司公告汇总：精华制药2025年年度股东会审议通过利润分配预案、日常关联交易预计及修改公司章程等多项议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","002349","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635870232","title":"精华制药：2025年度实现归母净利润2.30亿元，同比增长8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635870232","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635870232?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:45","pubTimestamp":1778834721,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药05月15日在投资者关系平台上答复投资者关心的问题。2025年度，扣除股份支付影响，公司实现归母净利润2.30亿元，同比增长8.38%，扣非归母净利润2.19亿元，同比增长11.96%。实现经营性现金流3.41亿元，同比增长9.60%，2025年度分红金额也有所提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500029428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635745001","title":"精华制药（002349）披露2025年年度股东会法律意见书，5月14日股价下跌1.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635745001","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635745001?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:35","pubTimestamp":1778769315,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，精华制药报收于7.26元，较前一交易日下跌1.22%，最新总市值为60.34亿元。该股当日开盘7.36元，最高7.4元，最低7.24元，成交额达8585.33万元，换手率为1.44%。近日，精华制药发布公告称，北京市盈科（南通）律师事务所出具法律意见书，确认精华制药集团股份有限公司2025年年度股东会的召集和召开程序、出席人员资格、召集人资格及表决程序符合相关法律法规及《公司章程》规定，表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","002349","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633815550","title":"股市必读：精华制药（002349）5月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2633815550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633815550?lang=zh_cn&edition=full","pubTime":"2026-05-07 02:32","pubTimestamp":1778092332,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，精华制药报收于7.52元，上涨0.0%，换手率1.72%，成交量14.04万手，成交额1.05亿元。对其他各月股东人数,投资者可通过现场或电子邮件等方式向公司提供证明其持有公司股份的书面文件,公司经核实股东身份后按照要求予以提供。交易信息汇总资金流向5月6日主力资金净流出350.51万元；游资资金净流出274.58万元；散户资金净流入625.09万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700001665.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632867743","title":"每周股票复盘：精华制药（002349）股东户数下降3.79%，一季报净利增5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632867743","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632867743?lang=zh_cn&edition=full","pubTime":"2026-05-03 05:56","pubTimestamp":1777758974,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，精华制药报收于7.52元，较上周的7.27元上涨3.44%。本周，精华制药4月30日盘中最高价报7.59元。股本股东变化截至2026年3月31日，精华制药股东户数为8.07万户，较2025年12月31日减少3181户，减幅3.79%。董事会已于2026年4月28日审议通过将预留授予日调整为2026年5月6日。公司原定于2026年4月21日确定预留授予，因需确保授予日为交易日并避开敏感期，故经董事会决议调整授予日为2026年5月6日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631518418","title":"图解精华制药一季报：第一季度单季净利润同比增长5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631518418","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631518418?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:12","pubTimestamp":1777461154,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药2026年一季报显示，一季度公司主营收入3.8亿元，同比上升4.46%；归母净利润6587.25万元，同比上升5.87%；扣非净利润6382.35万元，同比上升5.76%；负债率10.81%，投资收益71.15万元，财务费用-317.61万元，毛利率55.39%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900059747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631596720","title":"精华制药(002349)3月31日股东户数8.07万户，较上期减少3.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631596720","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631596720?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:52","pubTimestamp":1777456370,"startTime":"0","endTime":"0","summary":"证券之星消息，近日精华制药披露，截至2026年3月31日公司股东户数为8.07万户，较12月31日减少3181.0户，减幅为3.79%。在中药行业个股中，精华制药股东户数高于行业平均水平，截至3月31日，中药行业平均股东户数为5.36万户。从股价来看，2025年12月31日至2026年3月31日，精华制药区间涨幅为0.83%，在此期间股东户数减少3181.0户，减幅为3.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900056182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629402718","title":"精华制药（002349）2025年年报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2629402718","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629402718?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:32","pubTimestamp":1777041172,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期精华制药发布2025年年报。截至本报告期末，公司营业总收入14.6亿元，同比上升4.13%，归母净利润2.19亿元，同比上升3.12%。按单季度数据看，第四季度营业总收入3.68亿元，同比上升3.01%，第四季度归母净利润4291.21万元，同比下降11.37%。本报告期精华制药盈利能力上升，毛利率同比增幅4.45%，净利率同比增幅1.61%。本次财报公布的各项数据指标表现尚佳。去年的净利率为17.93%，算上全部成本后，公司产品或服务的附加值高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400065273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629824368","title":"精华制药（002349）披露“质量回报双提升”行动方案，4月23日股价下跌2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629824368","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629824368?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:55","pubTimestamp":1776938144,"startTime":"0","endTime":"0","summary":"截至2026年4月23日收盘，精华制药报收于7.22元，较前一交易日下跌2.04%，最新总市值为59.9亿元。该股当日开盘7.33元，最高7.36元，最低7.2元，成交额达1.11亿元，换手率为1.88%。公告显示，公司为落实稳市场、稳信心政策，制定“质量回报双提升”行动方案。通过现金分红、股权激励、股份回购、并购重组等方式加强市值管理，提升股东回报。2025年实施首期限制性股票激励计划，覆盖105人，授予1549.4万股。注重信息披露质量与投资者关系管理，多渠道开展交流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300049504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629019072","title":"精华制药(002349)3月31日股东户数8.07万户，较上期减少3.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629019072","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629019072?lang=zh_cn&edition=full","pubTime":"2026-04-22 17:28","pubTimestamp":1776850093,"startTime":"0","endTime":"0","summary":"证券之星消息，近日精华制药披露，截至2026年3月31日公司股东户数为8.07万户，较12月31日减少3181.0户，减幅为3.79%。在中药行业个股中，精华制药股东户数高于行业平均水平，截至3月31日，中药行业平均股东户数为5.35万户。从股价来看，2025年12月31日至2026年3月31日，精华制药区间涨幅为0.83%，在此期间股东户数减少3181.0户，减幅为3.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200040586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621859220","title":"股市必读：精华制药（002349）3月23日收盘跌8.13%，主力净流入1461.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621859220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621859220?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:00","pubTimestamp":1774288856,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，精华制药报收于6.78元，下跌8.13%，换手率4.53%，成交量36.87万手，成交额2.57亿元。交易信息汇总精华制药3月23日收盘价为6.78元，下跌8.13%，当日成交金额3687.34万元。该股已连续3个交易日下跌。前10个交易日内，主力资金累计净流入205.2万元，期间股价累计下跌10.48%；融资余额累计减少554.83万元，融券余量累计减少1.36万股。3月23日单日资金流向显示，主力资金净流入1461.69万元，游资资金净流入1323.92万元，散户资金净流出2785.61万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609106143","title":"精华制药：公司现金流状况良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2609106143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609106143?lang=zh_cn&edition=full","pubTime":"2026-02-05 08:45","pubTimestamp":1770252311,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药02月04日在投资者关系平台上答复投资者关心的问题。公司将在2026年4月23日披露2025年年度报告，请您关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500006422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","002349","159399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594231153","title":"精华制药最新公告：孙公司宁夏森萱因污染环境罪被判处罚金五十万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594231153","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594231153?lang=zh_cn&edition=full","pubTime":"2025-12-25 19:41","pubTimestamp":1766662871,"startTime":"0","endTime":"0","summary":"精华制药(002349.SZ)公告称，公司孙公司宁夏森萱药业有限公司因污染环境罪被判处罚金人民币五十万元，与已缴纳的罚款九十万元折抵后，无需再行缴纳。案件涉案金额较小，不会对公司2025年净利润产生重大影响。且宁夏森萱本案所述行为发生后高度重视，积极整改，已于2024年7月恢复正常生产经营。此案件司法裁判结果不会导致公司触及重大违法强制退市情形。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500030505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590839950","title":"精华制药：玛巴洛沙韦尚未具备商业化生产销售条件","url":"https://stock-news.laohu8.com/highlight/detail?id=2590839950","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590839950?lang=zh_cn&edition=full","pubTime":"2025-12-09 11:37","pubTimestamp":1765251459,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药(002349)12月09日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好，公司玛巴洛沙韦还在改进中，是不是意味着短期无法投放市场？精华制药回复：公司玛巴洛沙韦产品工艺优化工作尚在推进中，目前还未具备商业化生产销售的条件。感谢您对公司的关心！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900013670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590862399","title":"精华制药：二氧五环产销量基本保持平稳","url":"https://stock-news.laohu8.com/highlight/detail?id=2590862399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590862399?lang=zh_cn&edition=full","pubTime":"2025-12-09 11:37","pubTimestamp":1765251458,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药(002349)12月09日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好，公司二氧五环跟电解液高度关联，锂电池行业目前来说发展势头不错，为何公司二氧五环没有涨价？不符合客观逻辑啊，目前二氧五环是满产满销吗？精华制药回复：公司孙公司二氧五环产品主要应用与共聚甲醛的合成，小部分用于磷酸铁锂路线一次电池的电解液，该产品的定价参照市场需求确定，其产销量基本保持平稳。感谢您对公司的关心！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900013667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","002349","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589135821","title":"精华制药：正柴胡饮颗粒入选流感治疗指南","url":"https://stock-news.laohu8.com/highlight/detail?id=2589135821","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589135821?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:51","pubTimestamp":1765198280,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药12月08日在投资者关系平台上答复投资者关心的问题。请问公司目前产品可以应用于今年甲流的治疗有哪些？以上产品在医院及药房均可购买，感谢您对公司的关心。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800031680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","002349","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517971030","title":"精华制药：为遵循信息披露公平原则,公司会在定期报告披露相对应时点股东人数","url":"https://stock-news.laohu8.com/highlight/detail?id=2517971030","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517971030?lang=zh_cn&edition=full","pubTime":"2025-03-06 08:57","pubTimestamp":1741222634,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药(002349)03月05日在投资者关系平台上答复投资者关心的问题。投资者提问：股东人数多少？精华制药回复：尊敬的投资者，为遵循信息披露公平原则,公司会在定期报告披露相对应时点股东人数。对其他各月股东人数,投资者可通过现场或电子邮件等方式向公司提供证明其持有公司股份的书面文件,公司经核实股东身份后按照要求予以提供。感谢您对公司的关心!以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030600007479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512260134","title":"精华制药：公司尚在进行项目前期可行性方案论证等工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2512260134","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512260134?lang=zh_cn&edition=full","pubTime":"2025-02-18 17:30","pubTimestamp":1739871010,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药(002349)02月18日在投资者关系平台上答复投资者关心的问题。投资者：请问董秘，贵司现代化基地啥进展了？精华制药董秘：公司尚在进行项目前期可行性方案论证等工作，有进展将及时履行信息披露义务。感谢您对公司的关心！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021800030490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782880885681,"stockEarnings":[{"period":"1week","weight":-0.0505},{"period":"1month","weight":-0.1191},{"period":"3month","weight":-0.1613},{"period":"6month","weight":-0.1335},{"period":"1year","weight":-0.1251},{"period":"ytd","weight":-0.1335}],"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0369},{"period":"6month","weight":0.0316},{"period":"1year","weight":0.1887},{"period":"ytd","weight":0.0316}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"精华制药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"80720人(较上一季度减少3.79%)","perCapita":"10086股","listingDate":"2010-02-03","address":"江苏省南通市崇川区港闸经济开发区兴泰路9号","registeredCapital":"83112万元","survey":" 精华制药集团股份有限公司的主营业务是传统中成药制剂、化学原料药及中间体、化工医药中间体、中药材及中药饮片、大健康产品等的研发、生产和销售。公司的主要产品是王氏保赤丸、季德胜蛇药片、正柴胡饮颗粒、黄芪泡腾片、当归、白芍、苯巴比妥、氟尿嘧啶、二氧六环、甲基肼。","listedPrice":19.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"精华制药(002349)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供精华制药(002349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"精华制药,002349,精华制药股票,精华制药股票老虎,精华制药股票老虎国际,精华制药行情,精华制药股票行情,精华制药股价,精华制药股市,精华制药股票价格,精华制药股票交易,精华制药股票购买,精华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"精华制药(002349)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供精华制药(002349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}